Anaphylaxis cluster sparks new peptide warning

A recent death and a string of anaphylaxis notifications linked to unapproved peptides have prompted a health department to re-issue clinical guidance Clinicians have been encouraged to have “open, non-judgemental discussions with patients about the use of unapproved peptides” after a cluster of anaphylaxis cases in Victoria. Earlier this week, the Victorian Department of Health